IDIBAPS is a partner in the OperA project, financed by the Horizon Europe programme
Maria Pellisé will lead the Institute's contribution to the project, which is aimed at validating the use of artificial intelligence-assisted colonos1
Maria Pellisé will lead the Institute's contribution to the project, which is aimed at validating the use of artificial intelligence-assisted colonos1
Trial TILs001, which is open to patients with metastatic triple-negative breast cancer, is the first study to assess the safety and efficacy of TILs1
The University of Pennsylvania professor and pioneer in developing cancer therapies using T cells covered the history, current state, and future chal1
In the next three years, the projects selected, led by Elías Campo, Patrícia Pérez Galán and Josep Dalmau, are aimed at studying how cancer cells mod1
The study, published in the journal The Lancet Neurology, compares the cognitive and psychiatric symptoms of patients with those of schizophrenia and1
Autism is a disorder that affects 1 in 100 children. Early diagnosis helps in starting treatment and reducing symptoms
The project will be carried out by researchers from the IDIBAPS Systems Neurosciences group, led by Mavi Sánchez-Vives.
The grant, worth 150,000 euros over 18 months, will enable the group led by Jaime de la Rocha to improve the prototype of a 24/7 automatic behavioura1
Physical activity improves cognitive function, memory, efficiency and attention and also prevents cognitive decline. It increases serotonin levels1